Tomoyuki Watanabe

1.6k total citations
60 papers, 814 citations indexed

About

Tomoyuki Watanabe is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Tomoyuki Watanabe has authored 60 papers receiving a total of 814 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Public Health, Environmental and Occupational Health, 14 papers in Hematology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Tomoyuki Watanabe's work include Acute Lymphoblastic Leukemia research (14 papers), Acute Myeloid Leukemia Research (12 papers) and Lymphoma Diagnosis and Treatment (10 papers). Tomoyuki Watanabe is often cited by papers focused on Acute Lymphoblastic Leukemia research (14 papers), Acute Myeloid Leukemia Research (12 papers) and Lymphoma Diagnosis and Treatment (10 papers). Tomoyuki Watanabe collaborates with scholars based in Japan, United States and United Kingdom. Tomoyuki Watanabe's co-authors include Mamoru Senna, Akira Kusai, Naoki Wakiyama, Tetsuhiko Isobe, Sunao Hasegawa, Keizo Horibe, Masaru Miyao, Yoko Konagaya, Ryōji Kobayashi and Akiko Saito and has published in prestigious journals such as Blood, International Journal of Pharmaceutics and British Journal Of Nutrition.

In The Last Decade

Tomoyuki Watanabe

56 papers receiving 780 citations

Peers

Countries citing papers authored by Tomoyuki Watanabe

Since Specialization

Citations

This map shows the geographic impact of Tomoyuki Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoyuki Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoyuki Watanabe more than expected).

Fields of papers citing papers by Tomoyuki Watanabe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoyuki Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoyuki Watanabe. The network helps show where Tomoyuki Watanabe may publish in the future.

Co-authorship network of co-authors of Tomoyuki Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoyuki Watanabe. A scholar is included among the top collaborators of Tomoyuki Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoyuki Watanabe. Tomoyuki Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Continuous high-soy protein soymilk intake affects ordinary walking speed in the Japanese pre-frail and frail elderly: a randomized controlled trial 2025 ·BMC Geriatrics ·Naoko Sato, (unknown), Makoto Sugawara, Rei Unno, (unknown), M. Iwasaki, Tomoyuki Watanabe, (unknown), (unknown)	1
2	Retinal Pigment Epithelial Tear and Retinal Detachment Following Hypotony After Trabeculectomy: A Case Report 2025 ·Cureus ·Yuka Saito, Akira Watanabe, Tomoyuki Watanabe, Tadashi Nakano	0
3	Safety and Effectiveness Analyses of Dolutegravir/Lamivudine in Patients with HIV: 2-Year Report of Post-Marketing Surveillance in Japan 2023 ·Advances in Therapy ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Eiji Kurosaki, (unknown), Tomoyuki Watanabe	0
4	Allogeneic Hematopoietic Cell Transplantation for Juvenile Myelomonocytic Leukemia with a Busulfan, Fludarabine, and Melphalan Regimen: JPLSG JMML-11 2023 ·Transplantation and Cellular Therapy ·Kazuo Sakashita, Nao Yoshida, Hideki Muramatsu, Yoshitoshi Ohtsuka, Kenichiro Watanabe, Miharu Yabe, Harumi Kakuda, Yuko Honda, Tomoyuki Watanabe, (unknown), Shigeru Ohmori, Kazuyuki Matsuda, Yuki Yuza, Akiko Saito, Keizo Horibe, Souichi Adachi, Atsushi Manabe	1
5	Awareness of folic acid use increases its consumption, and reduces the risk of spina bifida 2015 ·British Journal Of Nutrition ·Atsuo Kondo, Nobuhito Morota, Hiroaki Date, Kazuhisa Yoshifuji, (unknown), Minoru Miyazato, Reizo Shirane, Hideki Sakai, (unknown), Tomoyuki Watanabe	18
6	Prognostic impact of cytogenetic abnormalities in children and adolescents with mature B‐cell non‐Hodgkin lymphoma: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) 2015 ·Pediatric Blood & Cancer ·Masahiro Sekimizu, Tetsuya Mori, Akira Kikuchi, Tetsuo Mitsui, (unknown), Ryōji Kobayashi, Naoto Fujita, Hiroko Inada, Tetsuya Takimoto, Akiko Saito, Tomoyuki Watanabe, Junichiro Fujimoto, Atsuko Nakazawa, Koichi Ohshima, Keizo Horibe, Masahito Tsurusawa	5
7	Evaluation of multimodal factors for the certification of long-term care insurance among community-dwelling elderly: A four-year follow-up study 2014 ·Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics ·Yoko Konagaya, Tomoyuki Watanabe	10
8	Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group 2014 ·Blood Cancer Journal ·H. Matsuo, (unknown), Daisuke Tomizawa, Tomoyuki Watanabe, Akiko Saito, J Fujimoto, Keizo Horibe, (unknown), (unknown), Hiroshi Itoh, Hideki Nakayama, Akitoshi Kinoshita, Takashi Taga, Akio Tawa, Tomohiko Taki, Shiro Tanaka, Souichi Adachi	17
9	Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group 2013 ·International Journal of Hematology ·Daisuke Tomizawa, Akio Tawa, Tomoyuki Watanabe, Akiko Saito, Kazuko Kudo, Takashi Taga, (unknown), Akira Shimada, Kiminori Terui, Hiroshi Moritake, Akitoshi Kinoshita, Hiroyuki Takahashi, Hideki Nakayama, Nobutaka Kiyokawa, Keiichi Isoyama, Shuki Mizutani, Junichi Hara, Keizo Horibe, Tatsutoshi Nakahata, Souichi Adachi	37
10	Prognosis of mature T cell lymphoma is poorer than that of diffuse large B cell lymphoma in IPI low-risk group, but not in intermediate- and high-risk groups 2012 ·International Journal of Hematology ·Rika Kihara, Tomoyuki Watanabe, Takahiro Yano, Naokuni Uike, Seiichi Okamura, Fumio Kawano, Shuichi Hanada, Kazutaka Sunami, (unknown), Morio Sawamura, (unknown), Takeshi Shimomura, Kiyoshi Kitano, Yuki Kojima, Keizo Horibe, Hirokazu Nagai	6
11	Cancer mortality among atomic bomb survivors exposed as children 2011 ·Environmental Health and Preventive Medicine ·Hitomi Goto, Tomoyuki Watanabe, Masaru Miyao, Hiromi Fukuda, Yuzo Sato, Yoshiharu Oshida	14
12	Whole brain radiation alone produces favourable outcomes for AIDS‐related primary central nervous system lymphoma in the HAART era 2010 ·European Journal Of Haematology ·Hirokazu Nagai, Takashi Odawara, Atsushi Ajisawa, Shotaro Hagiwara, Tomoyuki Watanabe, Tomoko Uehira, Hideki Uchiumi, (unknown), Toshikazu Miyakawa, Akira Watanabe, (unknown), Mitsuru Konishi, Seiji Saito, Soichiro Takahama, Masao Tateyama, Seiji Okada	14
13	Frequency and clinical characteristics of the individuals with presenile dementia in Aichi prefecture 2009 ·Rinsho Shinkeigaku ·Yoko Konagaya, Tomoyuki Watanabe, (unknown)	0
14	FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non‐Hodgkin lymphoma 2009 ·British Journal of Haematology ·Hyuntae Park, Tomohiko Taki, Megumi Oda, Tomoyuki Watanabe, Keiko Yumura‐Yagi, Ryōji Kobayashi, Nobuhiro Suzuki, Junichi Hara, Keizo Horibe, Yasuhide Hayashi	87
15	Hiroshima survivors exposed to very low doses of A-bomb primary radiation showed a high risk for cancers 2008 ·Environmental Health and Preventive Medicine ·Tomoyuki Watanabe, Masaru Miyao, Ryumon Honda, Yuichi Yamada	25
16	Remission induction therapy containing rituximab markedly improved the outcome of untreated mature B cell lymphoma 2008 ·British Journal of Haematology ·Hirokazu Nagai, Takahiro Yano, Tomoyuki Watanabe, Naokuni Uike, Seiichi Okamura, Shuichi Hanada, Fumio Kawano, Kazutaka Sunami, (unknown), Morio Sawamura, Tetsuo Nishiura, Tomomitsu Hotta, Keizo Horibe	7
17	Associations of Periodontal Damage and Tooth Loss with Atherogenic Factors among Patients with Type 2 Diabetes Mellitus 2007 ·Internal Medicine ·(unknown), Kenji Wakai, Kunio Yamanouchi, Yoshiharu Oshida, Masaru Miyao, Tomoyuki Watanabe, Yuzo Sato	26
18	Validation of the Telephone Interview for Cognitive Status (TICS) in Japanese 2007 ·International Journal of Geriatric Psychiatry ·Yoko Konagaya, Yukihiko Washimi, Hideyuki Hattori, Akinori Takeda, Tomoyuki Watanabe, Toshiki Ohta	27
19	Dynamic model of facial color for facial image synthesis in a virtual arm wrestling 2004 ·Society of Instrument and Control Engineers of Japan ·Takashi Yamada, Tomoyuki Watanabe	1
20	Stabilization of amorphous indomethacin by co-grinding in a ternary mixture 2002 ·International Journal of Pharmaceutics ·Tomoyuki Watanabe, (unknown), Naoki Wakiyama, Akira Kusai, Mamoru Senna	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact